{"schema_version":"secwatch.filing_event.v1","accession":"0001140361-25-041286","form_type":"8-K","ticker":"PDSB","cik":"0001472091","company_name":"PDS Biotechnology Corp","filed_at":"2025-11-10T23:59:59+00:00","discovered_at":"2026-05-14T18:02:39.474304+00:00","generated_at":"2026-05-16T22:20:44.062257+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"PDS Biotech reports positive translational data for PDS0101 and PDS01ADC at SITC 2025","bullets":["Translational study of PDS0101 combo in 50 patients shows multiple serum biomarkers predict clinical benefit accurately.","PDS01ADC monotherapy increases NK cells with tumor-killing phenotypes and decreases poor-response NK cells in advanced solid tumors.","PDS01ADC increases self-replicating stem-like memory T cells (CD8 and CD4) associated with disease stabilization in 28 patients.","Data selected among top 150 abstracts at SITC; presented under NCI CRADA collaboration."],"urls":{"canonical":"https://secwatch.observer/filing/0001140361-25-041286","json":"https://secwatch.observer/filing/0001140361-25-041286.json","markdown":"https://secwatch.observer/filing/0001140361-25-041286.md","text":"https://secwatch.observer/filing/0001140361-25-041286.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1472091/000114036125041286/0001140361-25-041286-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1472091/000114036125041286/ef20058659_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T22:20:44.062257+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}